Hologic to Release First Quarter Fiscal 2014 Operating Results on Monday, February 3, 2014
BEDFORD, Mass., Jan. 9, 2014 /PRNewswire/ -- Hologic, Inc. (Hologic or the Company) (NASDAQ: HOLX), a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products, with an emphasis on serving the healthcare needs of women, today announced plans to release its first quarter fiscal 2014 operating results on Monday, February 3, 2014, after market close. In conjunction with the release, management will host a conference call on Monday, February 3, 2014, at 5:00 p.m. (Eastern).
Interested participants may listen to the call by dialing 877-397-0292 or 719-325-4942 for international callers and referencing participant code 6120983 approximately 15 minutes prior to the call on February 3rd. For those unable to participate in the live broadcast, a replay will be available two hours after the call ends through Friday, February 21, 2014, at 888-203-1112 or 719-457-0820 for international callers, access code 6120983.
The Company will also provide a live webcast of the call. Interested participants may access the webcast on the Company's website at http://investors.hologic.com/investors-overview. A replay of the call will be archived on the Company's website and a PowerPoint presentation related to the conference call will be posted to the site after market close on Monday, February 3, 2014.
About Hologic, Inc.:
Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems, and surgical products, with an emphasis on serving the healthcare needs of women. The Company operates four core business units focused on breast health, diagnostics, GYN surgical and skeletal health. With a comprehensive suite of technologies and a robust research and development program, Hologic is committed to improving lives. The Company is headquartered in Massachusetts. For more information, visit www.hologic.com.
SOURCE Hologic, Inc.
More by this Source
Hologic Announces Positive Results of February AMA CPT Editorial Panel Meeting
Mar 06, 2014, 07:00 ET
Tre nuove pubblicazioni revisionate da ricercatori indipendenti per convalidare ulteriormente i vantaggi della Mammografia (Tomosintesi) 3D di Hologic nello screening del cancro al seno
Mar 05, 2014, 03:00 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.